Jul 27, 2022 / 02:00PM GMT
Unidentified Company Representative -
Good morning, and welcome to the HTG Molecular KOL webinar. (Operator Instructions) As a reminder, this call is being recorded, and a replay will be made available on the HTG Molecular website following the conclusion of the event.
I'd now like to turn the call over to John Lubniewski, President and Chief Executive Officer of HTG Molecular. Please go ahead, John.
John L. Lubniewski - HTG Molecular Diagnostics, Inc. - President, CEO & Director
Yes. Thank you, and I'd like to welcome all of our attendees this morning. I think we've got a really interesting program. We're going to talk about what we see as a very disruptive and exciting new way to develop new lead candidates for pharmaceuticals.
And with us today, we've got an outstanding cast of speakers, most notably, Dr. Robert Spitale from UC Irvine as well as some internal speakers from HTG. So without further ado, I'd like to introduce Dr. Steve Barat. Steve runs our pharma programs. He joined us from Johnson and Janssen, where he was the U.S. Head of
HTG Molecular Diagnostics Inc Host a Key Opinion Leader (KOL) Webinar Transcript
Jul 27, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers